VISTAKONŽ Pharmaceuticals, LLC    SantenŽ Pharmaceutical, Co., LTD. T.R.U.S.T. QUIXIN® to keep you covered.

PROFESSIONALS

Dual Mechanism of Action with QUIXIN®

Dual Mechanism of Action

  • Inhibits both topoisomerase IV and DNA gyrase enzymes
  • Interferes with DNA replication, transcription, repair, and recombination
  • Levofloxacin, gatifloxacin and moxifloxacin have very similar mechanisms of action1

Resistance

  • Resistance to levofloxacin due to spontaneous mutation in vitro is a rare occurrence (10-9 to 10-10)

 

 

 

 

1. Data on file, VISTAKON® Pharmaceuticals. Antimicrobial susceptibility: nationwide patterns in the T.R.U.S.T. surveillance program.